Six courses of intensified CHOP plus G-CSF compared to eight courses of standard CHOP in patients with intermediate-risk aggressive non-Hodgkin lymphoma. Results of a prospective randomized HOVON trial

L Verdonck, G.W. van Imhoff, J.M.M. Raemakers, C.G. Verhoef, M.H.H. Kramer, G.J. Ossenkoppele, J.K. Doorduijn, L.A.M.H. Meulendijks, W.N. van Wieringen, P. Sonneveld

Research output: Contribution to JournalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)14
Issue number11
Publication statusPublished - 2005

Bibliographical note

47th Annual Meeting of the American-Society-of-Hematology DEC 10-13, 2005 Atlanta, GA

Cite this